Correlation Between Radient Technologies and Australis Capital
Can any of the company-specific risk be diversified away by investing in both Radient Technologies and Australis Capital at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Radient Technologies and Australis Capital into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Radient Technologies and Australis Capital, you can compare the effects of market volatilities on Radient Technologies and Australis Capital and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Radient Technologies with a short position of Australis Capital. Check out your portfolio center. Please also check ongoing floating volatility patterns of Radient Technologies and Australis Capital.
Diversification Opportunities for Radient Technologies and Australis Capital
0.2 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Radient and Australis is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Radient Technologies and Australis Capital in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Australis Capital and Radient Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Radient Technologies are associated (or correlated) with Australis Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Australis Capital has no effect on the direction of Radient Technologies i.e., Radient Technologies and Australis Capital go up and down completely randomly.
Pair Corralation between Radient Technologies and Australis Capital
Assuming the 90 days horizon Radient Technologies is expected to under-perform the Australis Capital. But the pink sheet apears to be less risky and, when comparing its historical volatility, Radient Technologies is 10.12 times less risky than Australis Capital. The pink sheet trades about -0.13 of its potential returns per unit of risk. The Australis Capital is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 0.01 in Australis Capital on September 19, 2024 and sell it today you would earn a total of 0.00 from holding Australis Capital or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Radient Technologies vs. Australis Capital
Performance |
Timeline |
Radient Technologies |
Australis Capital |
Radient Technologies and Australis Capital Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Radient Technologies and Australis Capital
The main advantage of trading using opposite Radient Technologies and Australis Capital positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Radient Technologies position performs unexpectedly, Australis Capital can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Australis Capital will offset losses from the drop in Australis Capital's long position.Radient Technologies vs. HempAmericana | Radient Technologies vs. Nextleaf Solutions | Radient Technologies vs. Mydecine Innovations Group | Radient Technologies vs. Abattis Bioceuticals Corp |
Australis Capital vs. Body and Mind | Australis Capital vs. Radient Technologies | Australis Capital vs. Choom Holdings | Australis Capital vs. Khiron Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |